Top news of the week: 24.11.2020.
Biotechnology, Therapy, Medicine, Oncology, Stem cell, Clinical trial
Healthcare
RT @SarahE_Richards: A year in the making and 8,000 words later @WIRED, I am deeply honored to share the moving story of @bryceolson's genomics quest to find a cancer drug in a system that does not share data. Thanks to formidable editor @markrobsf and photog @Reuben_Wu 1/
https://t.co/2aRHKIAOsD
OpenOne Man’s Search for the DNA Data That Could Save His Life
The genetic correlations that could help Bryce Olson find a drug that works against his cancer are a scattered mess. Why don’t we have a better system for analyzing this kind of information?
AstraZeneca
[3] It has Research and development concentrated in three strategic centres; Cambridge, Gothenburg, Sweden and Gaithersburg, U.S.[4] AstraZeneca has a portfolio of products for …
Seattle Children’s Therapeutics leverages biotech innovation in quest for new treatments for kids #BioTech #innovation via https://t.co/2sI0UxJbpn https://t.co/7xp7t68DPw
OpenSeattle Children’s Therapeutics leverages biotech innovation in quest for new treatments for kids
Can a nonprofit research institution operate more effectively by taking a page from the commercial biotech industry? That's the idea behind Seattle Children's Therapeutics, a new effort by ...
RT @olfrach: A Look at the Future of Biotechnology in the Medical Sector https://t.co/uIOboErswy via @techatlast https://t.co/1f5XzkjdFi
OpenA Look at the Future of Biotechnology in the Medical Sector
When it comes to medical progress and developing new cures for ailments, biotechnology is one of the most promising fields right now.
RT @shanthirex: $PFE $BNTX $LLY $DTIL $APVO $EIGR and more
biotech stocks on the move...
https://t.co/mnLl6FSjFQ
OpenThe Daily Biotech Pulse: Amarin Surges On Vascepa Data, Mesoblast Rallies On Novartis Deal, Decision Day For Eiger
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 19) Aligos Therapeutics Inc (...
Clinical Catch-Up: November 16-20
Although there was quite a bit of clinical trial news overall, the biggest focus was on COVID-19 vaccines, with the three leaders in the U.S. and Europe all presenting clinical trial news. ...
Avrobio tracks improvements in first patient treated with Gaucher gene therapy https://t.co/hqLIuMBj2G https://t.co/i5ug6GUV6x
OpenAvrobio tracks improvements in first patient treated with Gaucher gene therapy
Avrobio has shared data on the first Gaucher disease patient to receive its gene therapy AVR-RD-02. The patient, who was stable on enzyme replacement therapy at baseline, experienced a 22% ...
Ex-AstraZeneca executive launches D3 Bio with $200M
D3 Bio has emerged with $200 million from a syndicate of heavy hitters and an ex-AstraZeneca leader in the CEO role. George Chen, M.D., set up D3 Bio after seven years at AstraZeneca and ...